中国医药能否在海外市场实现产业升级？

💊中国医药能否在海外市场实现产业升级？
💊How can Chinese pharmaceutical companies achieve industrial upgrading in overseas markets?
🌏随着中国医药健康产业逐步走向全球，中文EMBA第32班学员周玉建（幂方健康基金创始人及管理合伙人）与我们分享了他眼里的医药产业升级之路：从传统的原料药供应，再到仿制药生产，如今不少企业已开始研发具有自主知识产权的创新药。🏥未来，中国药业将进一步组建海外临床与商业团队，迈向创新药品自主产业化，在全球医药产业链中实现稳步升级。📈 #新加坡国立大学EMBA #商学院 #校友分享 #医药健康 #全球市场 #创新药 #产业升级
🌏As China's medical and health industry gradually goes global, Zhou Yujian, student of NUS EMBA-C Intake 32 and founder and managing partner of Med-Fine Capital, shared his insights on the upgrading path of the pharmaceutical industry. According to him, the industry is progressing from traditional raw material supply to the production of generic drugs, and now many companies are beginning to develop innovative drugs with independent intellectual property rights. 🏥In the future, the Chinese pharmaceutical industry will further establish overseas clinical and commercial teams, advancing towards the independent industrialization of innovative drugs and achieving steady upgrades within the global pharmaceutical industry chain.📈 #EMBA #nusembac #BussinessSchool #AlumniInsights #PharmaceuticalHealth #GlobalMarket #InnovativeDrugs #IndustryUpgrade